Kiniksa Pharmaceuticals
KNSA
#2412
Rank
C$10.68 B
Marketcap
๐Ÿ‡ง๐Ÿ‡ฒ
Country
C$135.95
Share price
-0.06%
Change (1 day)
135.49%
Change (1 year)

EPS for Kiniksa Pharmaceuticals (KNSA)

EPS in 2026 (TTM): C$2.01

According to Kiniksa Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is C$2.05. In 2025 the company made an earnings per share (EPS) of C$1.14 an increase over its 2024 EPS that were of C-$0.87.

EPS history for Kiniksa Pharmaceuticals from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$2.0176.05%
2025C$1.14-231.15%
2024C-$0.87-421.05%
2023C$0.27-92.8%
2022C$3.78-214.78%
2021C-$3.29-10.85%
2020C-$3.69-14.57%
2019C-$4.326.33%
2018C-$4.06

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
C-$1.93-194.41%๐Ÿ‡บ๐Ÿ‡ธ USA